a Rab10, a member of the Rab family, is localized to endocytic compartments and serves as a regulator of intracellular vesicle trafficking. Previous studies mainly paid attention to the role of Rab10 in transport.
I. Introduction
Thyroid cancer is a common type of tumor related to the endocrine system and its incidence has been steadily rising in the past decades. [1] [2] [3] This disease mainly originates from follicular cells encompassing a range of differentiation from indolent cancer types (follicular or papillary thyroid cancer) to invasive and lethal cancer types (undifferentiated thyroid cancer). 4 This broad spectrum of development is partly linked to epigenetic dysregulation of genes associated with tumor differentiation, aggressive ability and metastatic potential. 5 Increasing evidence has demonstrated that the epithelial-mesenchymal transition (EMT) process plays a crucial role in cancer invasion and metastasis. [6] [7] [8] Therefore, it is desperately needed to explore novel biomarkers related to EMT and investigate the underlying molecular mechanisms for the purpose of facilitating the treatment of thyroid cancer.
The Rab family, belonging to the RAS superfamily of small GTPases, contains more than 60 members. 9, 10 These members act as a regulator of intercellular vesicle trafficking, receptor recycling and signal transduction. 11 These processes, in turn, mediate the normal membrane polarity. [12] [13] [14] Besides, these Rab GTPases can be activated by distinct types of Rab GEFs and down-regulated by Rab GAPs.
15 Rab10, a member of the Rab family, is an important participant in formation of endoplasmic reticulum, secretion of basement membrane and translocation of glucose transporter type 4. [16] [17] [18] Furthermore, Rab10 plays a crucial role in innate immune responses via regulating transport of toll-like receptor 4. 19, 20 Recently, Rab10 has been demonstrated to be aberrantly expressed in some types of cancers and show biological signicance in cancer progression. [21] [22] [23] However, the specic role of Rab10 in thyroid cancer remains unknown.
In this study, we demonstrated that Rab10 was elevated in thyroid cancer tissues and cell lines. Down-regulation of Rab10 inhibited hypoxia-induced migration, invasion and EMT of thyroid cancer cells. In addition, we found that Rab10 downregulation exerted the inhibitory effect on thyroid cancer cells exposed to hypoxia by targeting HIF-1a through the PI3K/Akt pathway.
II Results

Expression of Rab10 is up-regulated in thyroid cancer tissues and cell lines
To investigate the effect of Rab10 on thyroid cancer, we rst measured the expression levels of Rab10 mRNA and protein in thyroid cancer tissues and adjacent normal tissues from 42 patients. The results showed that the expression of Rab10 in thyroid cancer tissues was signicantly increased at both mRNA and protein levels in comparison with the normal tissues ( Fig. 1A and B) . The expression of Rab10 was also evaluated in thyroid cancer cell lines. As shown in Fig. 1C and D, Rab10 mRNA and protein levels in WRO and 8505C cell lines were markedly higher than those in the normal thyroid cell line Nthyori 3-1.
Down-regulation of Rab10 inhibits the viability of thyroid cancer cells exposed to hypoxia
We rst examined the effect of hypoxia on thyroid cancer cell viability. As shown in Fig. 2A and B, no obvious effect on the cell viability was observed aer hypoxia exposure for 24 h while the viability was signicantly reduced aer hypoxia exposure for 48 h. Therefore, WRO and 8505C cells were treated with hypoxia for 24 h in the subsequent experiments.
Next, we decreased the expression of Rab10 in thyroid cancer cells. Down-regulation of Rab10 in WRO and 8505C cells was conrmed by western blot analysis ( Fig. 2C and D) . Then we detected the effect of Rab10 down-regulation on cell viability under hypoxic conditions. The results showed that the inhibitory effect of Rab10 down-regulation was much stronger on WRO cell viability under hypoxic conditions than those incubated under normoxic conditions (Fig. 2E) . Similar results were obtained in 8505C cells (Fig. 2F) .
Down-regulation of Rab10 inhibits hypoxia-induced migration, invasion and EMT of thyroid cancer cells
Hypoxia has been demonstrated to induce cancer cell migration and invasion. 24 So we detected the effect of Rab10 downregulation on hypoxia-induced cell migration and invasion. As shown in Fig. 3A and B, hypoxia remarkably increased the migratory and invasive abilities of WRO cells, which were decreased by Rab10 down-regulation. Similarly, we found that down-regulation of Rab10 inhibited hypoxia-induced migration and invasion of 8505C cells ( Fig. 3C and D) .
The EMT process plays an essential role in cancer progression and the hypoxic environment can stimulate this process, 6-8,25 so we investigated the effect of Rab10 down-regulation on hypoxiainduced EMT in thyroid cancer cells. As shown in Fig. 3E , the expression of E-cadherin was decreased while the expression of N-cadherin was increased aer hypoxia treatment in WRO cells. But the EMT process was reversed by Rab10 down-regulation in WRO cells cultured under hypoxic conditions (Fig. 3E) . Similar results were found in 8505C cells (Fig. 3F ).
HIF-1a and the PI3K/Akt pathway are involved in the inhibitory effect of Rab10 down-regulation on thyroid cancer cell invasion and EMT induced by hypoxia HIF-1a is known as a regulator of cancer cell invasion and EMT under hypoxic conditions.
26-29 So, we investigated whether Rab10 down-regulation exerted the inhibitory effect on hypoxiainduced invasion and EMT by regulating the HIF-1a expression. As expected, Rab10 down-regulation decreased hypoxia-induced HIF-1a expression in WRO cells (Fig. 4A ). To further conrm the involvement of HIF-1a in hypoxia-regulated invasion and EMT, HIF-1a shRNA was transfected into the WRO cells and the knockdown efficiency was veried by western blot analysis (Fig. 4B) . Moreover, the cell invasion assay showed that HIF-1a knockdown inhibited hypoxia-induced invasion of WRO cells and Rab10 down-regulation enhanced the inhibitory effect (Fig. 4C) . We also found that HIF-1a knockdown suppressed hypoxia-induced decrease in E-cadherin expression in WRO cells and the suppressive effect was potentiated by Rab10 downregulation (Fig. 4D) .
Numerous studies have shown that the PI3K/Akt signaling pathway could regulate the levels of HIF-1a.
30,31 Thus, we assumed that Rab10 down-regulation might mediate the expression of HIF-1a via the PI3K/Akt pathway. The results showed that hypoxia treatment obviously increased the expression of p-PI3K and p-Akt in WRO cells, but the effect was signicantly impaired by Rab10 down-regulation ( Fig. 4E and F) .
III. Discussion
According to statistics, over 6% of thyroid cancers are characterized by vigorous migratory and invasive capabilities which are considered crucial signs of a lethal outcome. 32, 33 Thus, prevention of migration and invasion is a necessity for thyroid cancer therapy.
Rab10, a member of the Rab family, is localized to endocytic compartments and serves as a regulator of intracellular vesicle trafficking.
34 Rab10 deletion could decrease cell adhesion and affect a number of cell functions. 35 Previous studies mainly paid attention to the role of Rab10 in transport. Recently, Rab10 has been reported to be involved in progression of various cancers. For example, Wang et al. demonstrated the oncogenic role of Rab10 in hepatocellular cancer and its association with the poor prognosis of hepatocellular cancer patients. 22 Furthermore, Rab10 has been targeted to inhibit cell migration and invasion in osteosarcoma. 23 In this study, we found that Rab10 was highly expressed in thyroid cancer tissues and cell lines, indicating the potential role of Rab10 in thyroid cancer. The EMT process is an essential step during cancer cell migration and invasion.
6-8 A distinct hallmark of EMT is the loss or reduction of E-cadherin expression. 36 So far, a variety of EMT inducers have been identied and one of the vital factors is hypoxia. [37] [38] [39] [40] [41] Tissue hypoxia is caused by the poor development of angiogenic vessels.
42
Under hypoxic conditions, cell morphology will change and subsequently lead to a mesenchymal-like phenotype, which is an obvious feature of the EMT process. 8 In this study, we found that down-regulation of Rab10 inhibited hypoxia-induced migration, invasion and EMT of thyroid cancer cells. All these observations suggested that Rab10 down-regulation blocked thyroid cancer cell migration and invasion by suppressing EMT under hypoxic conditions.
HIF-1a, a signal transcription factor, is a hallmark of cell invasion and a crucial regulator of the EMT process.
26,27,43 HIF1a could be induced upon hypoxia, which will inuence the expression and activity of some important transcription factors and subsequently cause inhibition of E-cadherin in cancer cells. [27] [28] [29] In this study, we found that Rab10 down-regulation decreased hypoxia-induced HIF-1a expression in thyroid cancer cells; HIF-1a knockdown inhibited hypoxia-induced decrease in E-cadherin expression and the inhibitory effect was enhanced by Rab10 down-regulation. Our ndings suggested that Rab10 down-regulation blocked hypoxia-induced EMT in thyroid cancer cells by suppressing HIF-1a expression.
Increasing evidence has demonstrated that the PI3K/Akt pathway could mediate HIF-1a expression in cancer cells. For example, Sun et al. reported that PI3K inhibitors signicantly prevented HIF-1a induction under hypoxic conditions in prostate cancer. 44 In our study, we found that hypoxia treatment markedly elevated the expression of p-PI3K and p-Akt in thyroid cancer cells and this effect was reversed aer Rab10 down-regulation. These results indicated that down-regulation of Rab10 inhibited hypoxiainduced EMT in thyroid cancer cells by reducing HIF-1a expression through regulation of the PI3K/Akt signaling pathway.
In conclusion, we demonstrated that Rab10 was highly expressed in thyroid cancer tissues and cell lines. Downregulation of Rab10 inhibited hypoxia-induced migration, invasion and EMT of thyroid cancer cells. Moreover, HIF-1a and the PI3K/Akt pathway were involved in the inhibitory effect of Rab10 down-regulation on thyroid cancer cell invasion and EMT induced by hypoxia. Taken together, our study provided further evidence to support the role of Rab10 as a therapeutic target for thyroid cancer.
IV. Materials and methods
Patients and tissue samples
This study was approved by the Ethics Committee of Huaihe Hospital of Henan University (Kaifeng, China). A total of 42 patients with thyroid cancer participated in the study and provided informed consent. None of the patients received any adjuvant therapies before surgery. All thyroid cancer tissues and corresponding adjacent normal tissues were collected from the patients and then stored at À80 C for future experiments. This study was approved by the Ethics Committee of Huaihe Hospital of Henan University, and written informed consent was obtained from all patients.
Cell lines and cell culture
Human thyroid cancer cell lines (WRO and 8505C) and thyroid follicular epithelial cell line Nthy-ori 3-1 were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). All cell lines were cultured in RPMI-1640 (Gibco, Rockville, MD, USA) containing 10% fetal bovine serum (FBS; Gibco) and 100 U ml À1 penicillin/streptomycin and incubated at 37 C in a standard humidied atmosphere with 5% CO 2 .
To induce hypoxia, cells were seeded in a six-well plate and continuously gassed with 5% CO 2 an internal control. The relative expression was calculated using the 2 ÀDDC t method.
Western blot analysis
Tissues or cells were lysed with lysis buffer and the protein lysates were separated by 12% SDS-PAGE and then transferred onto PVDF membranes (Millipore, Billerica, MA, USA). Aer blocking in 5% non-fat milk for 2 h, the membranes were incubated with the primary antibodies against Rab10 (1:1000), E-cadherin ( . Subsequently, the membranes were washed and incubated with appropriate secondary antibodies. All antibodies were obtained from Invitrogen. The immunoreactive bands were detected using an enhanced chemiluminescence kit (Pierce, Rockford, IL, USA) and quantied using the Quantity One soware.
Cell transfection
The shRNA against Rab10 or HIF-1a was purchased from GeneCopoeia (Rockville, MD, USA). A non-specic shRNA was used as a negative control. All the shRNA sequences were as follows:
Cells were transfected with shRab10, shHIF-1a or shControl using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions. The transfection efficiency was conrmed by western blot analysis.
Cell viability assay
The effect of hypoxia on cell viability was determined by the MTT assay. In brief, cells (1 Â 10 4 per well) were exposed to hypoxia for indicated times in a 96-well plate. Then MTT solution (5 mg ml À1 ; Sigma, St. Louis, MO, USA) was added to each well and cells were further cultured for 4 h at 37 C. Subsequently, the culture medium was removed and DMSO (Sigma) was added. The optical density was measured at 570 nm using a microplate reader.
Transwell assay
Transwell chambers were used to assess cell migration and invasion. 24-well plates with Matrigel-free inserts were for cell migration and those with Matrigel-coated inserts were for cell invasion. Briey, the upper chamber was lled with serum-free medium and 2 Â 10 4 cells were added. Culture medium with 10% FBS was added to the lower chamber as a chemoattractant. Aer incubation for 24 h, cells on the upper surface of the insert were removed and cells on the lower surface of the insert were xed and stained with 0.1% crystal violet. The number of cells in ve random elds was counted under a microscope (400Â).
Statistical analysis
Data were collected from three independent experiments and shown as means AE standard deviation (SD). Statistical analysis was performed using SPSS 19.0 soware. Student's t-test or oneway ANOVA was used for the comparison between different groups. Differences were considered statistically signicant when the p value was less than 0.05.
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